Oncology
Conference Coverage
A look at lung cancer screening in resource-limited countries
Interim report from IASLC highlights unique challenges faced by low- and middle-income countries.
News
FDA approves Enhertu (trastuzumab deruxtecan) for HER2 lung cancer
“These results establish the new standard of care for patients with NSCLC harboring HER2 mutations.”
Conference Coverage
Air pollution contribution to lung cancer may be underestimated
A study of women with lung cancer who never smoked suggests that air pollution may be a larger risk factor for lung cancer than currently...
News
Genetic counseling for cancer often costs patients nothing
Genetic counseling is an important feature of cancer care that can affect treatment decisions and surveillance. But coverage of genetic counseling...
News
Updates on treatment/prevention of VTE in cancer patients
“Because patients with cancer have a baseline increased risk of VTE, compared with patients without cancer, the combination of both COVID-19 and...
Latest News
Blood test for cancer available, but is it ready for prime time?
“The devil is in the details to ensure the test can accurately detect very early cancers and there is a pathway for subsequent workup.”
News
New blood test could reshape early CRC screening
A new assay that identifies a specific combination of microRNA strands may expand colorectal cancer screening to younger ages in the face of...
News
Patient CRC screening preferences don’t match what they’re being offered
The greater preference for noninvasive screening tests over a colonoscopy may partly explain stagnant screening rates, experts suggest.